Carl Goldfischer, M.D.

Carl Goldfischer, M.D.

DirectoratEnliven Therapeutics· In the 2023 proxy

Carl Goldfischer, M.D. is Director of Enliven Therapeutics.

Experience

  1. Enliven TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +178%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?